U.S. Army’s Hemp Research, Mississippi’s Medical Cannabis Program, and Japan’s Synthetic Cannabinoid Gray Market
Veriheal
JULY 8, 2022
At the program’s launch, those with cancer, HIV/AIDS, sickle cell, terminal illnesses, or any medical conditions which cause seizures, chronic pain, and other ailments will be covered under the list of applicable conditions. In 2015 , synthetic cannabinoid JWH-018 caused a 28-year-old man to experience the symptoms of a stroke.
Let's personalize your content